rs186950965
Variant summary
Our verdict is Benign. The variant received -9 ACMG points: 0P and 9B. BP4_StrongBP6BS1
The NM_001128178.3(NPHP1):c.1913A>G(p.Gln638Arg) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000102 in 1,614,146 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 16/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_001128178.3 missense
Scores
Clinical Significance
Conservation
Publications
- Joubert syndrome with renal defectInheritance: AR Classification: DEFINITIVE, MODERATE, SUPPORTIVE Submitted by: Orphanet, Ambry Genetics, G2P
- nephronophthisis 1Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, G2P, ClinGen, Labcorp Genetics (formerly Invitae)
- Bardet-Biedl syndromeInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
- Senior-Loken syndromeInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Benign. The variant received -9 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_001128178.3. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| NPHP1 | NM_001128178.3 | MANE Select | c.1913A>G | p.Gln638Arg | missense | Exon 20 of 20 | NP_001121650.1 | ||
| NPHP1 | NM_000272.5 | c.2081A>G | p.Gln694Arg | missense | Exon 20 of 20 | NP_000263.2 | |||
| NPHP1 | NM_207181.4 | c.2078A>G | p.Gln693Arg | missense | Exon 20 of 20 | NP_997064.2 |
Ensembl Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| NPHP1 | ENST00000445609.7 | TSL:1 MANE Select | c.1913A>G | p.Gln638Arg | missense | Exon 20 of 20 | ENSP00000389879.3 | ||
| NPHP1 | ENST00000316534.8 | TSL:1 | c.2081A>G | p.Gln694Arg | missense | Exon 20 of 20 | ENSP00000313169.4 | ||
| NPHP1 | ENST00000393272.7 | TSL:1 | c.2078A>G | p.Gln693Arg | missense | Exon 20 of 20 | ENSP00000376953.3 |
Frequencies
GnomAD3 genomes AF: 0.000197 AC: 30AN: 152160Hom.: 0 Cov.: 33 show subpopulations
GnomAD2 exomes AF: 0.000410 AC: 103AN: 251490 AF XY: 0.000419 show subpopulations
GnomAD4 exome AF: 0.0000917 AC: 134AN: 1461868Hom.: 1 Cov.: 31 AF XY: 0.0000880 AC XY: 64AN XY: 727238 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.000197 AC: 30AN: 152278Hom.: 0 Cov.: 33 AF XY: 0.000228 AC XY: 17AN XY: 74448 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
not specified Benign:2
Inborn genetic diseases Uncertain:1
The c.2081A>G (p.Q694R) alteration is located in exon 20 (coding exon 20) of the NPHP1 gene. This alteration results from a A to G substitution at nucleotide position 2081, causing the glutamine (Q) at amino acid position 694 to be replaced by an arginine (R). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear.
Nephronophthisis Benign:1
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at